Indivior Pharmaceuticals, Inc. Share Price
Stocks
INDV
US45579U1097
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Nasdaq
21:00:00 02/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 36.28 USD | +2.57% |
|
+4.98% | +1.11% |
| Market Cap | 4.28B 3.82B 3.51B 3.19B 5.98B 405B 6.1B 41.9B 16.89B 214B 16.07B 15.73B 676B | P/E 2026 * |
9.75x | P/E 2027 * | 8.84x |
|---|---|---|---|---|---|
| Enterprise Value | 4.27B 3.81B 3.5B 3.18B 5.97B 404B 6.08B 41.78B 16.84B 213B 16.03B 15.68B 674B | EV / Sales 2026 * |
3.21x | EV / Sales 2027 * | 2.65x |
| Free-Float |
98.2% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INDV | Delayed | |
CBOE
| INDV | Real-time | |
|
Tradegate
| E7P | Real-time | |
|
Deutsche Boerse AG
| E7P | Delayed | |
|
Börse Stuttgart
| E7P | Delayed | |
|
Boerse Muenchen
| E7P | Real-time | |
|
Xetra
| E7P | Delayed |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 day | +2.57% | ||
| 1 week | +4.98% | ||
| Current month | +2.57% | ||
| 1 month | +1.60% | ||
| 3 months | -9.32% | ||
| 6 months | -3.66% | ||
| Current year | +1.11% |
| 1 week | 33.84 |  | 37.02 |
| 1 month | 32.31 | | 37.02 |
| Current year | 27.68 | | 42.81 |
| 1 year | 27.68 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/08/26 | Buy | Controller/Auditor | 1,500 | 0.0012% | ||
| 05/08/26 | Buy | Controller/Auditor | 1,500 | 0.0012% | ||
| 10/07/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.57% | +4.98% | +23.53% | +82.86% | 4.28B | |
| -0.46% | +10.31% | +63.52% | +143.15% | 1,257B | |
| -0.97% | +1.60% | +43.25% | +80.09% | 651B | |
| -2.05% | +0.73% | +32.47% | +101.62% | 510B | |
| -0.18% | -0.65% | +52.76% | +67.08% | 388B | |
| -0.78% | +5.51% | +72.55% | +44.25% | 366B | |
| +0.76% | +2.76% | +33.01% | +58.80% | 303B | |
| -0.06% | +8.11% | +12.12% | +34.98% | 288B | |
| -0.12% | +4.68% | +55.97% | +74.59% | 252B | |
| -0.21% | +7.34% | +42.19% | +109.69% | 211B | |
| Average | +0.28% | +4.63% | +43.14% | +79.71% | 423.09B | |
| Weighted average by Cap. | -0.29% | +5.30% | +49.20% | +93.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33B 1.19B 1.09B 993M 1.86B 126B 1.9B 13.03B 5.25B 66.56B 5B 4.89B 210B | 1.4B 1.25B 1.15B 1.04B 1.96B 132B 1.99B 13.7B 5.52B 69.93B 5.25B 5.14B 221B |
| Net income | 474M 423M 389M 353M 663M 44.9B 676M 4.64B 1.87B 23.7B 1.78B 1.74B 74.85B | 530M 473M 434M 395M 741M 50.17B 755M 5.19B 2.09B 26.48B 1.99B 1.95B 83.64B |
| Net Debt | -12.5M -11.16M -10.24M -9.32M -17.47M -1.18B -17.81M -122M -49.31M -625M -46.91M -45.91M -1.97B | -570M -509M -467M -425M -796M -53.96B -812M -5.58B -2.25B -28.48B -2.14B -2.09B -89.96B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/11/26 | US$36.28 | +2.57% | 4,869,435 |
| 30/10/26 | US$35.37 | +0.34% | 4,607,363 |
| 29/10/26 | US$35.25 | +1.38% | 5,720,372 |
| 28/10/26 | US$34.77 | +0.14% | 1,530,302 |
| 27/10/26 | US$34.72 | +0.46% | 2,410,659 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
